Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The atypical neuroleptic concept].

J M Azorin1, D Dassa, M Jalfre

  • 1Clinique de Psychiatrie, CHU Timone, Marseille.

L'Encephale
|September 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design of a brain-machine interface for reducing false activations of a lower-limb exoskeleton based on error related potential.

Computer methods and programs in biomedicine·2024
Same author

Analysis of Error Potentials generated by a lower limb exoskeleton feedback in a BMI for gait control<sup></sup>.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2023
Same author

Transfer Learning with CNN Models for Brain-Machine Interfaces to command lower-limb exoskeletons: A Solution for Limited Data<sup></sup>.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2023
Same author

Minimum clinically important differences for the Functioning Assessment Short Test and a battery of neuropsychological tests in bipolar disorders: results from the FACE-BD cohort.

Epidemiology and psychiatric sciences·2020
Same author

Effects of an Exoskeleton-Assisted Gait Motor Imagery Training in Functional Brain Connectivity.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2020
Same author

The implications of hypersomnia in the context of major depression: Results from a large, international, observational study.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2019
Same journal

Measuring antidepressant side effects in military personnel - Clinical validation of the French version of the UKU-SERS-Pat Scale: A comparative study of patient and clinician ratings.

L'Encephale·2026
Same journal

[Empowerment in addictology].

L'Encephale·2026
Same journal

Evaluation of the links between smoking and conspiracy mentality.

L'Encephale·2026
Same journal

Use of a relevance assessment tool in therapeutic residential care: A real world study.

L'Encephale·2026
Same journal

Prevalence and characteristics of domestic violence in a sample of adult psychiatric outpatients: A cross-sectional study.

L'Encephale·2026
Same journal

From representations to practice: how professionals describe supporting parents with psychiatric or somatic illness or disability.

L'Encephale·2026
See all related articles

Atypical neuroleptics, dopamine (DA) receptor blockers, offer improved efficacy and fewer side effects than typical antipsychotics. Their distinct actions on brain pathways and receptor profiles explain these therapeutic advantages.

Area of Science:

  • Pharmacology
  • Neuroscience

Context:

  • Atypical neuroleptics represent a significant advancement over typical antipsychotics.
  • They are defined by their reduced propensity for inducing parkinsonian side effects and tardive dyskinesias.

Purpose:

  • To elucidate the pharmacological distinctions and mechanisms of action differentiating atypical from typical neuroleptics.
  • To explore the diverse classes and receptor-binding profiles of atypical antipsychotic agents.

Summary:

  • Atypical neuroleptics are dopamine (DA) receptor blockers with lower risks of parkinsonian side effects and tardive dyskinesias.
  • They encompass various classes, including D2 receptor blockers, D1 antagonists, partial D2 agonists, and multi-acting receptor antagonists (e.g., clozapine, risperidone).
  • Their therapeutic advantages may stem from preferential action on mesolimbic and mesocortical DA systems over striatal pathways and specific receptor affinities, such as higher serotonin 5HT2 receptor affinity.

Related Experiment Videos

Impact:

  • Understanding these differences aids in developing more effective and safer antipsychotic treatments.
  • Identifies potential therapeutic targets and mechanisms for managing schizophrenia, particularly negative symptoms and treatment resistance.